AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2025
Jun 30, 2025
32559_dirs_2025-06-30_adeee702-3473-4647-9379-dedd5b26d2ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2025-06-27
Reporting Person: Gengos Andrew (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-27 | Common Stock | P | 5000.00 | $3.9267 | Acquired | 20000.00 | Direct |
| 2025-06-27 | Common Stock | P | 5000.00 | $3.9299 | Acquired | 25000.00 | Direct |